What Is GPR120? Its Role in Metabolism and Inflammation

GPR120, also known as free fatty acid receptor 4 (FFAR4), is a protein on the surface of cells that detects long-chain fatty acids, especially omega-3 fats like DHA and EPA. When these fats bind to GPR120, the receptor triggers a cascade of signals inside the cell that dampen inflammation and improve how the body handles sugar and fat. The receptor turns up in a surprising number of tissues, from immune cells and fat deposits to taste buds on your tongue and microglia in your brain, and its influence on metabolic health has made it a serious target for drug development.

A Fatty Acid Sensor on Many Cell Types

Your cells communicate using a huge family of receptors called G-protein-coupled receptors, or GPCRs. GPR120 belongs to this family but responds specifically to medium- and long-chain fatty acids. It shares that general job description with a related receptor called GPR40 (FFAR1), though the two are not closely related in their protein structure. Research comparing them found that the amino acid residues GPR120 uses to grab onto fatty acids are actually more similar to those of a completely different lipid receptor than to GPR40’s binding site.¹ That structural independence matters because it means drugs can be designed to hit GPR120 selectively without also activating GPR40, which plays a different role in the pancreas.

GPR120 was first noticed in the gut, where it helps cells sense the fatty acids arriving from a meal. But its expression has since been confirmed in macrophages (the immune system’s cleanup crew), adipose tissue (both white and brown fat), skeletal muscle, the liver, the brain, the tongue, and even pancreatic islet cells. Each tissue uses GPR120 signaling for slightly different purposes, but two themes recur across nearly all of them: reduced inflammation and improved metabolic function.

How GPR120 Puts Out Inflammatory Fires

The anti-inflammatory action of GPR120 is arguably its best-studied function. In a landmark study published in Cell, researchers showed that stimulating GPR120 with omega-3 fatty acids or a synthetic agonist produced broad anti-inflammatory effects in macrophages. Crucially, knocking down GPR120 wiped out those effects entirely. In live mice, omega-3 treatment suppressed inflammation and improved whole-body insulin sensitivity in normal animals but had no such benefit in mice lacking GPR120.² That finding was a turning point: it established GPR120 as a key mediator of the health benefits people associate with fish oil, not just a bystander.

The molecular details have been filled in since then. When omega-3 fats activate GPR120, the receptor recruits a signaling partner called β-arrestin2. That complex then blocks a pro-inflammatory hub known as TAK1/TAB1, which in turn keeps two major inflammatory pathways quiet: NF-κB and the NLRP3 inflammasome.³ In plain terms, GPR120 activation intercepts the signal before inflammation ramps up, rather than trying to clean up afterward. That upstream blockade explains why the anti-inflammatory reach of GPR120 is so broad: it is not targeting one inflammatory molecule but shutting off the switch that powers many of them.

Brown Fat, White Fat, and Burning Calories

One of the more exciting areas of GPR120 research involves its influence on fat tissue thermogenesis, the process by which your body burns fat to generate heat. You have two main types of fat: white fat, which stores energy, and brown fat, which burns it. A third category, “beige” fat, appears when white fat cells are coaxed into behaving more like brown fat. GPR120 activation promotes all three responses.

In mice treated with a GPR120 agonist called GW9508, brown fat ramped up its production of key heat-generating proteins, and white fat developed clusters of the multilocular beige cells that signal active browning. When the researchers repeated the experiment in mice lacking GPR120, the thermogenic response was blunted: brown fat showed larger lipid droplets (a sign of sluggish activity) and oxygen consumption was lower.⁴ A critical piece of this puzzle is FGF21, a hormone released from fat cells during GPR120 activation. Mice lacking FGF21 showed severely impaired browning and thermogenic gene expression in response to the same GPR120 agonist, indicating that FGF21 is the downstream messenger carrying much of the signal.⁴

Separate work confirmed this pathway using a plant-derived compound called loureirin B, which raised the proportion of omega-3 fatty acids in both brown and white fat, activated GPR120, and upregulated UCP1, the protein most directly responsible for thermogenesis. Blocking GPR120 abolished the thermogenic effect in cultured brown fat cells.⁵ For people interested in the metabolic side of weight management, this makes GPR120 a compelling target: activating it does not just reduce inflammation but actually turns up the rate at which fat is burned for heat.

Insulin Sensitivity and Skeletal Muscle

Your muscles account for the majority of the sugar your body pulls out of the bloodstream after a meal, so anything that makes muscle cells more responsive to insulin has outsized effects on blood-sugar control. Mice lacking GPR120 showed clear skeletal muscle insulin resistance, with about a 31% drop in the glucose infusion rate needed to maintain normal blood sugar during a clamp test.⁶

The mechanism in muscle appears to involve an energy-sensing enzyme called AMPK. When DHA (the omega-3 fatty acid that serves as GPR120’s main natural ligand) binds the receptor on muscle cells, it triggers a rise in intracellular calcium, which in turn activates AMPK. Activated AMPK drives the sugar transporter GLUT4 to the cell surface, allowing more glucose in. Knocking down GPR120 in muscle cells eliminated the DHA-driven glucose uptake.⁷ This is a separate pathway from the β-arrestin2 anti-inflammatory mechanism active in macrophages, which underscores that GPR120’s signaling is tissue-dependent rather than one-size-fits-all.

Pancreatic Islets and Beta Cell Protection

GPR120 is present in the insulin-producing islets of the human pancreas, but its role there is nuanced. In human islet tissue, GPR120 activation by omega-3 fatty acids prevented the type of cell death that high-fat conditions normally trigger in beta cells, and reducing GPR120 levels weakened that protective effect.⁸ That anti-apoptotic effect could be clinically meaningful because progressive beta cell loss is one of the ways type 2 diabetes worsens over time.

Interestingly, though, a study that mapped GPR120 expression within mouse islets found it was most abundant not in beta cells but in the neighboring delta cells, which release somatostatin. A selective GPR120 agonist had no direct effect on insulin secretion under either basal or glucose-stimulated conditions.⁹ So GPR120 in the pancreas seems more about keeping beta cells alive under metabolic stress than about directly boosting insulin release, a distinction that matters for how future drugs are designed.

Liver Protection Against Fatty Liver Disease

The liver sits at the crossroads of fat and sugar metabolism, and it is also heavily affected by the chronic low-grade inflammation that accompanies obesity. Two independent lines of research point to GPR120 as protective here. In one, a GPR120 agonist reduced signs of fat accumulation (steatosis) in mice fed a high-fat, high-sugar diet, and with longer treatment it also decreased collagen buildup and fibrosis, the scarring that marks the progression from simple fatty liver to more dangerous forms of the disease.¹⁰ In another study using a different agonist, GPR120 activation suppressed macrophage infiltration in the liver, lowered reactive oxygen species, and reversed inflammation and cell death driven by endoplasmic reticulum stress in dietary-induced steatohepatitis.¹¹ Both studies are in mice, but they suggest GPR120 agonists could eventually have a role in managing nonalcoholic fatty liver disease, a condition that currently has limited pharmaceutical options.

GPR120 in the Brain

The brain was not initially expected to be a major site of GPR120 activity, but it turns out the receptor is expressed on microglia, the brain’s resident immune cells, in both mice and humans. Researchers found GPR120 mRNA enriched in microglia of the nucleus accumbens, a reward-related brain region, and activating GPR120 centrally suppressed microglial reactivity and reduced sickness- and anxiety-like behaviors in mice.¹²

In the hypothalamus, the brain region that regulates appetite and energy balance, GPR120 appears mainly in microglia rather than neurons. Using a non-selective agonist that activates both GPR120 and GPR40, researchers observed reduced expression of inflammatory genes and lower energy efficiency. When they selectively knocked down GPR120 in the hypothalamus, the anti-inflammatory benefit vanished and energy efficiency climbed back up.¹³ Separately, in cultured hypothalamic neurons, DHA pretreatment prevented inflammation triggered by TNF-alpha, and this protection depended on endogenous GPR120 levels.¹⁴ These findings raise the possibility that some of the well-known cognitive and mood benefits attributed to omega-3 supplementation may flow through GPR120 signaling in brain immune cells.

Tasting Fat on Your Tongue

Beyond metabolism and immunity, GPR120 appears to play a role in how you perceive dietary fat. In human taste tissue, GPR120 mRNA and protein are present in taste buds and the surrounding epithelium. Pharmacological testing showed that GPR120’s activation profile aligns with the sensation subjects describe as “fatty” rather than the scratchy or irritating quality sometimes associated with free fatty acids in the mouth.¹⁵ In mouse studies, a selective GPR120 agonist applied to the tongue triggered a rapid calcium signal in taste bud cells and stimulated secretion of pancreatobiliary juice, likely via a tongue-to-brain-to-gut reflex arc. The same agonist also modulated how strongly the mice preferred fat in their diet.¹⁶ This tongue-brain-gut connection means GPR120 could be involved in the very first step of dietary fat processing, even before the fat reaches your stomach.

A Human Genetic Variant Linked to Obesity

The case for GPR120’s clinical relevance got stronger when researchers sequenced the receptor’s gene in obese and lean European subjects. They identified a variant called p.R270H that disrupts GPR120 signaling activity. In genotyping of roughly 14,000 people, carrying the R270H mutation was associated with increased risk of obesity and insulin resistance.¹⁷ Cell lines engineered to express the mutant receptor showed reduced function across multiple signaling assays.¹⁸ This is the kind of convergence geneticists look for: a loss-of-function variant in a gene whose knockout in mice also produces obesity, lending confidence that the receptor matters in humans too, not just in animal models.

The Complicated Picture in Cancer

GPR120’s anti-inflammatory properties generally sound beneficial, but cancer adds an important wrinkle. In prostate cancer models, an omega-3-rich diet significantly slowed tumor growth compared to an omega-6-rich diet. The omega-3 tumors had fewer M2-polarized macrophages, which are a type of immune cell that tumors co-opt to suppress anti-tumor immunity and feed new blood vessels. DHA inhibited these pro-tumor macrophage behaviors, and the effect depended on GPR120 on the macrophages themselves: when bone marrow cells lacking GPR120 were transplanted into the mice, the omega-3 diet lost its ability to reduce M2 macrophage infiltration.¹⁹ Follow-up work confirmed the specificity: in mice receiving GPR120-knockout bone marrow, the percentage of M2 macrophages in tumors did not change between omega-3 and omega-6 diets, while mice with intact macrophage GPR120 showed a clear reduction.²⁰

However, in colorectal cancer, the story flips. Tumor tissues showed significantly higher GPR120 expression than adjacent normal tissue, and that expression climbed with more advanced disease stage and poorer differentiation. Activating GPR120 in colorectal cancer cell lines promoted cell migration and markers of epithelial-to-mesenchymal transition, a process linked to metastasis. Knocking down GPR120 in the cancer cells eliminated these pro-tumor effects.²¹ The takeaway is that GPR120 on immune cells tends to be anti-tumor, but GPR120 expressed directly by certain cancer cells can be co-opted to promote tumor growth. Context, specifically which cell type is expressing the receptor, determines whether the signal helps or hurts.

Drug Development and Remaining Hurdles

Given the breadth of GPR120’s metabolic and anti-inflammatory actions, pharmaceutical interest is substantial. The first well-known synthetic agonist, TUG-891, became a starting scaffold for many follow-on molecules aimed at treating type 2 diabetes.²² Researchers are particularly interested in β-arrestin-biased ligands, compounds that preferentially activate the anti-inflammatory arm of GPR120 signaling over other downstream pathways. But several obstacles remain. GPR120 expression patterns differ between rodents and humans, making it difficult to predict how a drug that works in mice will behave in people. Receptor desensitization, where prolonged stimulation causes the cell to dial down GPR120’s responsiveness, is a real concern for chronic treatment. And some agonists show off-target activity on GPR40 or other receptors, which could cause unwanted side effects.²³ No GPR120-selective drug has yet reached late-stage clinical trials, though the pipeline is active and growing.

GPR120 and Your Body Clock

An unexpected thread in GPR120 research connects the receptor to circadian biology. In mice fed a diet containing fish oil (rich in DHA and EPA), the peripheral liver clock shifted its timing more rapidly than in mice on a standard diet. In GPR120-deficient mice, this clock-shifting effect of fish oil was largely abolished, as were the acute changes in clock gene expression and insulin secretion that normally follow a fish-oil-containing meal.²⁴ Separately, GPR120 mRNA levels in the pituitary gland of mice showed a diurnal rhythm under normal feeding conditions, peaking in the late afternoon after blood fatty acid levels crested earlier in the day. That rhythm disappeared when feeding was restricted to nighttime hours only.²⁵ The implication is that GPR120 may serve as a nutrient-timing sensor, helping peripheral organs synchronize their metabolic activity with when and what you eat. For anyone thinking about meal timing or shift work, the idea that a fat sensor on your cells is helping calibrate your internal clock adds a new dimension to the old advice about eating on a regular schedule.